GO:0008380 | RNA splicing | 4.81e-07 | 4.69e-03 | 4.224 | 6 | 21 | 165 |
GO:0010467 | gene expression | 3.40e-06 | 3.32e-02 | 2.942 | 8 | 49 | 535 |
GO:0000398 | mRNA splicing, via spliceosome | 3.59e-06 | 3.51e-02 | 4.327 | 5 | 15 | 128 |
GO:0003723 | RNA binding | 5.07e-06 | 4.95e-02 | 3.642 | 6 | 22 | 247 |
GO:0005654 | nucleoplasm | 1.46e-05 | 1.42e-01 | 2.401 | 9 | 68 | 876 |
GO:0006406 | mRNA export from nucleus | 7.87e-05 | 7.68e-01 | 5.131 | 3 | 7 | 44 |
GO:0006379 | mRNA cleavage | 1.28e-04 | 1.00e+00 | 6.836 | 2 | 2 | 9 |
GO:0030529 | ribonucleoprotein complex | 5.02e-04 | 1.00e+00 | 4.233 | 3 | 5 | 82 |
GO:0004832 | valine-tRNA ligase activity | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.95e-03 | 1.00e+00 | 9.005 | 1 | 1 | 1 |
GO:0031124 | mRNA 3'-end processing | 2.05e-03 | 1.00e+00 | 4.876 | 2 | 4 | 35 |
GO:0006369 | termination of RNA polymerase II transcription | 2.42e-03 | 1.00e+00 | 4.758 | 2 | 5 | 38 |
GO:0006396 | RNA processing | 2.68e-03 | 1.00e+00 | 4.684 | 2 | 4 | 40 |
GO:0010994 | free ubiquitin chain polymerization | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 3.89e-03 | 1.00e+00 | 8.005 | 1 | 1 | 2 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.49e-03 | 1.00e+00 | 4.305 | 2 | 8 | 52 |
GO:0042826 | histone deacetylase binding | 5.56e-03 | 1.00e+00 | 4.147 | 2 | 5 | 58 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 2 | 3 |
GO:0071001 | U4/U6 snRNP | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 5.83e-03 | 1.00e+00 | 7.421 | 1 | 1 | 3 |
GO:0006464 | cellular protein modification process | 6.13e-03 | 1.00e+00 | 4.075 | 2 | 4 | 61 |
GO:0045292 | mRNA cis splicing, via spliceosome | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 2 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 7.76e-03 | 1.00e+00 | 7.005 | 1 | 1 | 4 |
GO:0001649 | osteoblast differentiation | 8.91e-03 | 1.00e+00 | 3.796 | 2 | 5 | 74 |
GO:0004521 | endoribonuclease activity | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0010458 | exit from mitosis | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0035519 | protein K29-linked ubiquitination | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:0005672 | transcription factor TFIIA complex | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0006282 | regulation of DNA repair | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0044314 | protein K27-linked ubiquitination | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 2 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0051488 | activation of anaphase-promoting complex activity | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 9.69e-03 | 1.00e+00 | 6.684 | 1 | 3 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 1 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0085020 | protein K6-linked ubiquitination | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.16e-02 | 1.00e+00 | 6.421 | 1 | 2 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 4 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0007617 | mating behavior | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0000339 | RNA cap binding | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 4 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 2 | 7 |
GO:0005845 | mRNA cap binding complex | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0006878 | cellular copper ion homeostasis | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 4 | 8 |
GO:0044822 | poly(A) RNA binding | 1.60e-02 | 1.00e+00 | 1.685 | 5 | 45 | 799 |
GO:0010225 | response to UV-C | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.74e-02 | 1.00e+00 | 5.836 | 1 | 3 | 9 |
GO:0005515 | protein binding | 1.92e-02 | 1.00e+00 | 0.696 | 13 | 198 | 4124 |
GO:0001967 | suckling behavior | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 4 | 11 |
GO:0008334 | histone mRNA metabolic process | 2.12e-02 | 1.00e+00 | 5.546 | 1 | 1 | 11 |
GO:0017025 | TBP-class protein binding | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 1 | 12 |
GO:0005634 | nucleus | 2.35e-02 | 1.00e+00 | 0.800 | 11 | 158 | 3246 |
GO:0005680 | anaphase-promoting complex | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 2 | 13 |
GO:0043393 | regulation of protein binding | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 2 | 14 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.70e-02 | 1.00e+00 | 2.177 | 3 | 23 | 341 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 4 | 15 |
GO:0070932 | histone H3 deacetylation | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 2 | 15 |
GO:0042802 | identical protein binding | 2.97e-02 | 1.00e+00 | 2.123 | 3 | 15 | 354 |
GO:0003887 | DNA-directed DNA polymerase activity | 3.07e-02 | 1.00e+00 | 5.005 | 1 | 2 | 16 |
GO:0044212 | transcription regulatory region DNA binding | 3.09e-02 | 1.00e+00 | 2.846 | 2 | 13 | 143 |
GO:0005640 | nuclear outer membrane | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 1 | 17 |
GO:0031047 | gene silencing by RNA | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 3 | 18 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.45e-02 | 1.00e+00 | 4.836 | 1 | 1 | 18 |
GO:0005739 | mitochondrion | 3.53e-02 | 1.00e+00 | 1.641 | 4 | 32 | 659 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 3.64e-02 | 1.00e+00 | 4.758 | 1 | 1 | 19 |
GO:0006913 | nucleocytoplasmic transport | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0070979 | protein K11-linked ubiquitination | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.82e-02 | 1.00e+00 | 4.684 | 1 | 1 | 20 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 4.01e-02 | 1.00e+00 | 4.613 | 1 | 2 | 21 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 4.20e-02 | 1.00e+00 | 4.546 | 1 | 1 | 22 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 4.39e-02 | 1.00e+00 | 4.482 | 1 | 2 | 23 |
GO:0000166 | nucleotide binding | 4.52e-02 | 1.00e+00 | 2.546 | 2 | 13 | 176 |
GO:0006370 | 7-methylguanosine mRNA capping | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 6 | 24 |
GO:0070534 | protein K63-linked ubiquitination | 4.57e-02 | 1.00e+00 | 4.421 | 1 | 3 | 24 |
GO:0004842 | ubiquitin-protein transferase activity | 4.66e-02 | 1.00e+00 | 2.522 | 2 | 17 | 179 |
GO:0030901 | midbrain development | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 1 | 25 |
GO:0010827 | regulation of glucose transport | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 7 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 4.76e-02 | 1.00e+00 | 4.362 | 1 | 3 | 25 |
GO:0016032 | viral process | 4.81e-02 | 1.00e+00 | 1.849 | 3 | 30 | 428 |
GO:0009267 | cellular response to starvation | 4.94e-02 | 1.00e+00 | 4.305 | 1 | 1 | 26 |
GO:0050885 | neuromuscular process controlling balance | 5.31e-02 | 1.00e+00 | 4.198 | 1 | 1 | 28 |
GO:0016881 | acid-amino acid ligase activity | 5.31e-02 | 1.00e+00 | 4.198 | 1 | 3 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 29 |
GO:0042752 | regulation of circadian rhythm | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 5 | 29 |
GO:0006446 | regulation of translational initiation | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 2 | 29 |
GO:0006281 | DNA repair | 5.83e-02 | 1.00e+00 | 2.340 | 2 | 24 | 203 |
GO:0007077 | mitotic nuclear envelope disassembly | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 9 | 32 |
GO:0015030 | Cajal body | 6.05e-02 | 1.00e+00 | 4.005 | 1 | 3 | 32 |
GO:0071407 | cellular response to organic cyclic compound | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 6.42e-02 | 1.00e+00 | 3.918 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 5 | 35 |
GO:0044297 | cell body | 6.60e-02 | 1.00e+00 | 3.876 | 1 | 5 | 35 |
GO:0008645 | hexose transport | 6.78e-02 | 1.00e+00 | 3.836 | 1 | 8 | 36 |
GO:0030900 | forebrain development | 6.78e-02 | 1.00e+00 | 3.836 | 1 | 2 | 36 |
GO:0003743 | translation initiation factor activity | 6.97e-02 | 1.00e+00 | 3.796 | 1 | 8 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 4 | 38 |
GO:0048511 | rhythmic process | 7.15e-02 | 1.00e+00 | 3.758 | 1 | 5 | 38 |
GO:0003684 | damaged DNA binding | 7.69e-02 | 1.00e+00 | 3.648 | 1 | 1 | 41 |
GO:0005730 | nucleolus | 7.80e-02 | 1.00e+00 | 1.078 | 5 | 74 | 1217 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 7.87e-02 | 1.00e+00 | 3.613 | 1 | 4 | 42 |
GO:0008203 | cholesterol metabolic process | 8.77e-02 | 1.00e+00 | 3.451 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 8.77e-02 | 1.00e+00 | 3.451 | 1 | 1 | 47 |
GO:0005524 | ATP binding | 8.88e-02 | 1.00e+00 | 1.205 | 4 | 37 | 892 |
GO:0015758 | glucose transport | 8.95e-02 | 1.00e+00 | 3.421 | 1 | 8 | 48 |
GO:0006310 | DNA recombination | 9.30e-02 | 1.00e+00 | 3.362 | 1 | 8 | 50 |
GO:0005643 | nuclear pore | 9.48e-02 | 1.00e+00 | 3.333 | 1 | 12 | 51 |
GO:0005681 | spliceosomal complex | 1.02e-01 | 1.00e+00 | 3.224 | 1 | 8 | 55 |
GO:0008584 | male gonad development | 1.05e-01 | 1.00e+00 | 3.173 | 1 | 1 | 57 |
GO:0000785 | chromatin | 1.09e-01 | 1.00e+00 | 3.123 | 1 | 6 | 59 |
GO:0005737 | cytoplasm | 1.12e-01 | 1.00e+00 | 0.643 | 8 | 127 | 2633 |
GO:0071013 | catalytic step 2 spliceosome | 1.12e-01 | 1.00e+00 | 3.075 | 1 | 5 | 61 |
GO:0030018 | Z disc | 1.18e-01 | 1.00e+00 | 3.005 | 1 | 3 | 64 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.19e-01 | 1.00e+00 | 2.983 | 1 | 7 | 65 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.23e-01 | 1.00e+00 | 2.939 | 1 | 5 | 67 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.25e-01 | 1.00e+00 | 1.697 | 2 | 17 | 317 |
GO:0030308 | negative regulation of cell growth | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.28e-01 | 1.00e+00 | 2.876 | 1 | 5 | 70 |
GO:0010951 | negative regulation of endopeptidase activity | 1.30e-01 | 1.00e+00 | 2.856 | 1 | 2 | 71 |
GO:0016363 | nuclear matrix | 1.33e-01 | 1.00e+00 | 2.816 | 1 | 10 | 73 |
GO:0044267 | cellular protein metabolic process | 1.48e-01 | 1.00e+00 | 1.546 | 2 | 14 | 352 |
GO:0005635 | nuclear envelope | 1.50e-01 | 1.00e+00 | 2.630 | 1 | 6 | 83 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.52e-01 | 1.00e+00 | 2.613 | 1 | 5 | 84 |
GO:0008201 | heparin binding | 1.63e-01 | 1.00e+00 | 2.498 | 1 | 4 | 91 |
GO:0000209 | protein polyubiquitination | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.65e-01 | 1.00e+00 | 2.482 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.68e-01 | 1.00e+00 | 2.451 | 1 | 9 | 94 |
GO:0008017 | microtubule binding | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 9 | 97 |
GO:0006457 | protein folding | 1.73e-01 | 1.00e+00 | 2.406 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.76e-01 | 1.00e+00 | 2.376 | 1 | 6 | 99 |
GO:0006397 | mRNA processing | 1.94e-01 | 1.00e+00 | 2.224 | 1 | 12 | 110 |
GO:0042981 | regulation of apoptotic process | 1.97e-01 | 1.00e+00 | 2.198 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 2.02e-01 | 1.00e+00 | 2.160 | 1 | 8 | 115 |
GO:0016607 | nuclear speck | 2.13e-01 | 1.00e+00 | 2.075 | 1 | 8 | 122 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.22e-01 | 1.00e+00 | 1.173 | 2 | 29 | 456 |
GO:0001701 | in utero embryonic development | 2.61e-01 | 1.00e+00 | 1.739 | 1 | 7 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.71e-01 | 1.00e+00 | 1.675 | 1 | 18 | 161 |
GO:0046872 | metal ion binding | 2.71e-01 | 1.00e+00 | 0.723 | 3 | 24 | 934 |
GO:0005874 | microtubule | 2.74e-01 | 1.00e+00 | 1.657 | 1 | 10 | 163 |
GO:0003677 | DNA binding | 2.78e-01 | 1.00e+00 | 0.703 | 3 | 52 | 947 |
GO:0016071 | mRNA metabolic process | 2.84e-01 | 1.00e+00 | 1.596 | 1 | 10 | 170 |
GO:0019221 | cytokine-mediated signaling pathway | 2.87e-01 | 1.00e+00 | 1.579 | 1 | 10 | 172 |
GO:0006412 | translation | 2.95e-01 | 1.00e+00 | 1.530 | 1 | 12 | 178 |
GO:0003713 | transcription coactivator activity | 3.04e-01 | 1.00e+00 | 1.482 | 1 | 21 | 184 |
GO:0005975 | carbohydrate metabolic process | 3.06e-01 | 1.00e+00 | 1.466 | 1 | 10 | 186 |
GO:0016070 | RNA metabolic process | 3.09e-01 | 1.00e+00 | 1.451 | 1 | 10 | 188 |
GO:0005856 | cytoskeleton | 3.12e-01 | 1.00e+00 | 1.436 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 3.21e-01 | 1.00e+00 | 1.383 | 1 | 9 | 197 |
GO:0008134 | transcription factor binding | 3.37e-01 | 1.00e+00 | 1.298 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 3.39e-01 | 1.00e+00 | 1.291 | 1 | 7 | 210 |
GO:0030054 | cell junction | 3.49e-01 | 1.00e+00 | 1.237 | 1 | 5 | 218 |
GO:0030198 | extracellular matrix organization | 3.53e-01 | 1.00e+00 | 1.218 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.63e-01 | 1.00e+00 | 1.166 | 1 | 4 | 229 |
GO:0046982 | protein heterodimerization activity | 4.07e-01 | 1.00e+00 | 0.956 | 1 | 11 | 265 |
GO:0008285 | negative regulation of cell proliferation | 4.21e-01 | 1.00e+00 | 0.892 | 1 | 11 | 277 |
GO:0016020 | membrane | 4.23e-01 | 1.00e+00 | 0.353 | 3 | 56 | 1207 |
GO:0009986 | cell surface | 4.37e-01 | 1.00e+00 | 0.821 | 1 | 5 | 291 |
GO:0000278 | mitotic cell cycle | 4.63e-01 | 1.00e+00 | 0.711 | 1 | 28 | 314 |
GO:0005829 | cytosol | 4.69e-01 | 1.00e+00 | 0.202 | 4 | 88 | 1787 |
GO:0055085 | transmembrane transport | 4.79e-01 | 1.00e+00 | 0.644 | 1 | 13 | 329 |
GO:0045893 | positive regulation of transcription, DNA-templated | 5.27e-01 | 1.00e+00 | 0.447 | 1 | 21 | 377 |
GO:0042803 | protein homodimerization activity | 5.74e-01 | 1.00e+00 | 0.264 | 1 | 13 | 428 |
GO:0070062 | extracellular vesicular exosome | 6.42e-01 | 1.00e+00 | -0.090 | 3 | 51 | 1641 |
GO:0005887 | integral component of plasma membrane | 6.85e-01 | 1.00e+00 | -0.162 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 7.12e-01 | 1.00e+00 | -0.266 | 1 | 24 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.27e-01 | 1.00e+00 | -0.325 | 1 | 29 | 644 |
GO:0006355 | regulation of transcription, DNA-templated | 7.65e-01 | 1.00e+00 | -0.476 | 1 | 31 | 715 |
GO:0008270 | zinc ion binding | 7.70e-01 | 1.00e+00 | -0.500 | 1 | 39 | 727 |
GO:0044281 | small molecule metabolic process | 8.21e-01 | 1.00e+00 | -0.716 | 1 | 35 | 844 |
GO:0005886 | plasma membrane | 8.87e-01 | 1.00e+00 | -0.795 | 2 | 46 | 1784 |
GO:0006351 | transcription, DNA-templated | 8.91e-01 | 1.00e+00 | -1.066 | 1 | 47 | 1076 |
GO:0016021 | integral component of membrane | 9.61e-01 | 1.00e+00 | -1.570 | 1 | 19 | 1526 |